Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Drugs >

Elite Pharmaceuticals (ELTP)

Add ELTP Price Alert      Hide Sticky   Hide Intro
Moderator: Mocha Jet, Drugdoctor, joseytheoutlawwales, lasers, John_Langston, IB_
Search This Board: 
Last Post: 7/22/2017 9:49:02 AM - Followers: 835 - Board type: Free - Posts Today: 8

Elite Pharmaceuticals, Inc. (ELTP)

About Elite Pharmaceuticals
Elite Pharmaceuticals is a specialty pharmaceutical company specializing in niche generics and committed to the development of abuse-deterrent opioids to help curb diversion, misuse and abuse.  Elite has a pipeline of opioid abuse-deterrent products under development utilizing the company’s proprietary pharmacological abuse-deterrent technology. 
Located in Northvale, New Jersey, Elite operates a 55,000 square foot campus under Current Good Manufacturing Practice (“cGMP”) and is a United States Drug Enforcement Agency (“DEA”) registered facility for research, development, manufacturing and packaging of pharmaceutical products.
More information including Elite’s proprietary Abuse Resistant Technology can be found at

About Elite's Abuse Deterrent Technology

Elite's abuse deterrent products utilize the Company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
Elite continues to expands the intellectual property for the Company's opioid abuse deterrent technology. Elite now has four US patents, one European patent, and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.
Products & Pipeline
Elite’s principle product is SequestOx, an immediate-release oxycodone with sequestered naltrexone abuse-deterrent opioid product for the management of moderate to severe acute pain. Additional products include bariatric, cardiovascular, antihistamine, skeletal muscle relaxants, antipsychotic, tricyclic antidepressant, along with a number of approved products pending manufacturing site transfer.
Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy's Laboratories and Valeant Pharmaceuticals International. Additional information regarding Elite’s wholly owned products, partnerships, and contract manufacturing can be found at
The list of pipeline products can be found at
Nasrat Hakim, Chairman, President & Chief Executive Officer
Nasrat Hakim joined Elite in August 2013 as Director, President and Chief Executive Officer. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. Prior to his leading Elite, from 2004 to 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3,000 employees under his leadership.  Mr. Hakim also served as Corporate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company. 

Mr. Hakim’s career started in Medical Laboratory Technology from the Academy of Health and Sciences in the U.S. Army based in San Antonio, TX, followed by Graduate Certification in Regulatory Affairs (RAC) from California State University at Sacramento, Sacramento, CA; Bachelor in Chemistry/Bio-Chemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA; and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL.

Investor Relations and Corporate Inquiries

Dianne Will
Vice President of Investor Relations and Corporate Affairs
Telephone: 518-398-6222

Corporate Headquarters
165 Ludlow Avenue
Northvale, New Jersey 07647
Phone: 201-750-2646
Fax: 201-750-2755


Miscellaneous Links:
Elite Pharmaceuticals News
SEC Filings

FDA website

Clinical Trials.Gov
Yahoo Finance
Seeking Alpha

ELTP Daily Chart

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ELTP News: Confidential Treatment Order (ct Order) 07/12/2017 05:00:02 PM
ELTP News: Current Report Filing (8-k) 07/12/2017 04:02:10 PM
ELTP News: Current Report Filing (8-k) 07/07/2017 05:23:56 PM
ELTP News: Current Report Filing (8-k) 06/14/2017 05:08:53 PM
ELTP News: Annual Report (10-k) 06/14/2017 04:46:49 PM
#260714  Sticky Note Uh, no. WeeZuhl 06/13/17 02:21:47 PM
#247416  Sticky Note HERE is WHAT long term investors need to UNDERSTAND!!! Couch 03/21/17 06:12:24 PM
#236265  Sticky Note Elite Pharma: The company of firsts: namtae 12/14/16 12:32:00 PM
#234937  Sticky Note THIS IS WHAT YOU NEED TO KNOW BEFORE Couch 11/30/16 03:04:07 PM
#189564  Sticky Note $ELTP SequestOx and ADF Patents lasers 03/18/16 04:29:26 AM
#185967  Sticky Note The only topic here is ELTP. IH Admin [Dan] 02/23/16 09:32:46 PM
#266391   Theres still a billion shares still available for namtae 07/22/17 09:49:02 AM
#266390   You continually tell us about all of the tenor15824 07/22/17 09:37:58 AM
#266389   Just like NastyRat is doing with eltp shareholders? stockboy 07/22/17 09:20:39 AM
#266388   I know betsd took all your money laugh Padin 07/22/17 07:48:40 AM
#266387   45,000 shares still in the green, yes that's Couch 07/22/17 07:38:12 AM
#266386   YES its clear I've heard the same BS Couch 07/22/17 07:36:16 AM
#266385   LMAO; bought another 45,000 at .1082 = WHOOPSY!!!! Couch 07/22/17 07:34:12 AM
#266382   At 0.0001 after how many reverse splits? John_Langston 07/21/17 11:31:14 PM
#266381   Will you call the time to sell? conix 07/21/17 10:52:22 PM
#266380   45,000 shares purchased at .1082 on July 7th John_Langston 07/21/17 10:27:48 PM
#266379   YES it's clear to ALL that Elite is John_Langston 07/21/17 10:23:13 PM
#266378   Closed close the the 52 week low again John_Langston 07/21/17 10:19:30 PM
#266377   Yep that's why I'm buying all the shares Couch 07/21/17 10:06:23 PM
#266376   All can see this is going to sub-penny. Couch 07/21/17 10:04:59 PM
#266375   and the PPS closed GREEN today John_Langston 07/21/17 10:02:40 PM
#266374   By all means I will listen to Elite John_Langston 07/21/17 09:57:27 PM
#266373   Any TA specialists out there to offer some predictions? John_Langston 07/21/17 09:52:17 PM
#266371   Gee just more BS like the .02 cent Couch 07/21/17 09:48:08 PM
#266370   we will wait to hear from the FDA John_Langston 07/21/17 09:45:29 PM
#266367   That's not what Elite's IR Dianne, Stanley, Sofia Couch 07/21/17 08:50:43 PM
#266366   That's not what Elite's IR Dianne, Stanley, Sofia John_Langston 07/21/17 08:49:03 PM
#266365   Gee so many shares "sold" today the PPS Couch 07/21/17 08:47:01 PM
#266364   Yes I called a 10 plus bagger at Couch 07/21/17 08:46:08 PM
#266363   But nastyRAT said for me to buy and John_Langston 07/21/17 08:45:28 PM
#266362   Yes I bought another 45,000 shares at .1082. Couch 07/21/17 08:45:10 PM
#266361   LMAO; I agree the .02 cent "SOON" shares Couch 07/21/17 08:44:36 PM
#266360   Correct just like my 10 plus bagger at Couch 07/21/17 08:42:56 PM
#266359   Yes I called it too and it was John_Langston 07/21/17 08:42:09 PM
#266358   Sure K - been hearing the same BS Couch 07/21/17 08:42:03 PM
#266357   Held from 12¢ to 97¢ and back to Couch 07/21/17 08:41:26 PM
#266356   I know Elite could never have a 10 Couch 07/21/17 08:39:20 PM
#266355   Got it!!! = so the Elite PPS will Couch 07/21/17 08:37:51 PM
#266354   Yes by all means I will buy all John_Langston 07/21/17 08:36:23 PM
#266353   Gee and yet no .02 cent shares yet Couch 07/21/17 08:36:10 PM
#266352   Indeed I've been buying shares since the .06's Couch 07/21/17 08:35:16 PM
#266351   That sounds like the .02 cent BS I've Couch 07/21/17 08:34:29 PM
#266350   No way in hell the PPS could ever Couch 07/21/17 08:33:51 PM
#266349   YES another 20 years and counting = lol John_Langston 07/21/17 08:33:44 PM
#266348   It was lifted at 57¢. Couch 07/21/17 08:32:31 PM
#266347   I believe nastyRAT one day will move all Couch 07/21/17 08:31:38 PM
#266346   I never have been. I have always just Couch 07/21/17 08:30:43 PM
#266345   I would think the same as my .06, John_Langston 07/21/17 08:29:11 PM
#266344   My shares are in the red and I Couch 07/21/17 08:29:07 PM
#266343   Dang so that information wasn't in the information Couch 07/21/17 08:27:57 PM
#266342   Closed the HOD = WHOOPSY!!!!! Couch 07/21/17 08:26:43 PM
#266341   Correct 97¢ became 57¢ and then 45¢ and John_Langston 07/21/17 08:26:17 PM
#266340   Gee the PPS keeps "falling" and the PPS Couch 07/21/17 08:25:44 PM
#266339   how many more decades John_Langston 07/21/17 08:21:57 PM
#266338   GEE so nobody is selling John_Langston 07/21/17 08:19:08 PM
#266336   International Elite Pharma Inc. lasers 07/21/17 08:16:21 PM